We identified a Siglec-1 expressing subset of pDCs in human peripheral blood.
Siglec-1+ pDCs reveal a semi-mature and myeloid-like phenotype.
In vitro, Siglec-1 is induced by influenza virus in Siglec-1− blood pDCs.
Siglec-1+/Siglec-1− ratio is imbalanced in SLE and during acute immune responses.
Increased Siglec-1+/Siglec-1− ratio correlates with disease activity in SLE.